Welcome to the SWYAPC website

The information on these pages is intended as a guide only. Whilst we endeavour to keep such information as up to date as possible, we make no claim as to its total accuracy or completeness. Information is liable to change, and such changes may not be mirrored in this site. We do not accept liability for any loss or damage resulting from use of this site or reliance on its content. External links lead to sites and pages over which we have no control, and which we cannot verify for accuracy or content. The inclusion of a link on this website should not be taken as an endorsement of the linked website, nor of the accuracy or quality of the information on such sites.


Updates following the May 2019 Area Prescribing Committee Meeting


Red, Green, Amber and Green Specialist Indication



Desferrioxamine used for iron overdose

CoaguChek used for paediatric haematology

Budesonide orodisperisable tablets used for treatment of eosinophilic esophagitis (EoE) in adults

Diphoterine solution used as a spray/wash for caustic burns to skin/eye.

Gonasi as a sourced alternative as Pregnyl brand hCG has been discontinued for hypogonadotrophic hypogonadism

Spectinomycin used as an antibiotic for the treatment of gonorrhoea infections.

Atexolizumab for treatment of cancers

Niraparib for treatment of cancers

Alectinib for treatment of cancers



Semaglutide for Type 2 diabetes

Dulaglutide for Type 2 diabetes



Levamisole for paediatric nephrotic syndrome LTHT guidance

Lanthanum for reducing blood levels of phosphate regarding kidney disease


Green Specialist Initiation

Apomorphine for Parkinson’s disease

Imiquimod for anogenital warts

Goserelin for breast cancer

Opicapone for Parkinson’s disease


Flash Glucose Monitoring – Update May 2019

We are currently working with diabetes specialists in West Yorkshire and Harrogate to update our policies on flash glucose monitoring, following the publication of new guidance from NHS England, and agree a single policy for all nine clinical commissioning groups.  Some Interim WY&H guidance for Flash Glucose Monitoring  has been developed which describes the responsibilities of specialist, GP and patient.

Until a single policy has been agreed the 7 CCGs of the South West Yorkshire Area Prescribing Committee will start to implement the NHS England guidance Flash Glucose Monitoring: National Arrangements for Funding of Relevant Diabetes Patients.”  The Diabetes Specialist Teams in local areas will be responsible for assessing whether patients meet the criteria in this guidance, starting flash glucose monitoring and ongoing review.  The continued  supply of the flash glucose monitoring sensors will transfer to the patients GP practice.




Primary Care Antimicrobial Guidelines

On 16 January 2019 the South West Yorkshire Area Prescribing Committee approved local use of the new  NICE/PHE managing common infections guidance.

This supersedes our local primary care guideline. As NICE/PHE have not completed all sections yet, we will continue to use local guidelines for those sections.

NICE/PHE – introduction to guidelines

NICE/PHE table – managing common infections (whole guideline)


Valproate Pregnancy Prevention Programme

The following sections include new information about valproate and pregnancy: Medicines alerts and safety issues; mental health; patient information.


Skin preparations (including emollients)

West Yorkshire Fire & Rescue Service has produced YouTube Videos for the public and patients and one for healthcare professionals warning that skin preparations can increase the risk of a fire developing. The YouTube videos have been added to the following sections of the website for information and discussion:  Medicines Alerts and Safety Issues, Patient Information and Care Homes. There is also information on the Fire Service’s website. The MHRA has issued a press release.